| Literature DB >> 24512828 |
Hoàng Thị Lâm1, Linda Ekerljung, Anders Bjerg, Nguyễn Văn T Tng, Bo Lundbäck, Eva Rönmark.
Abstract
BACKGROUND: The knowledge about allergic sensitization and its relationship with clinical symptoms and diseases among adults in South-East Asia is poor. The aim of this study was to investigate the prevalence and pattern of allergic sensitization and the association with asthma and allergic rhinitis in adults in urban and rural Vietnam.Entities:
Year: 2014 PMID: 24512828 PMCID: PMC3923743 DOI: 10.1186/2045-7022-4-6
Source DB: PubMed Journal: Clin Transl Allergy ISSN: 2045-7022 Impact factor: 5.871
Figure 1Flow chart of the study design and study population.
The representativeness of the clinically examined sample based on the questionnaire study data*
| Ever asthma | 4.5 | 4.3 | 4.1 | 3.8 | 0.467 |
| Physician diagnosed asthma | 3.9 | 3.3 | 3.2 | 3.0 | 0.581 |
| Asthma medicine | 2.1 | 1.9 | 1.6 | 1.1 | 0.121 |
| Allergic rhinitis | 17.2 | 20.7 | 19.2 | 16.8 | 0.013 |
| Recurrent wheeze | 3.7 | 3.4 | 3.7 | 3.2 | 0.579 |
| Wheezing without a cold | 3.2 | 2.8 | 3.4 | 3.2 | 0.396 |
| Attack of SOB | 5.2 | 4.9 | 5.8 | 4.7 | 0.433 |
| Dyspnea | 3.5 | 3.6 | 3.9 | 4.0 | 0.458 |
*Prevalence (%) of symptoms and conditions in the entire cohort, among those invited to the clinical examinations, and those who participated in the clinical examinations.
**Difference between participants in skin prick testing and non-participants in ages ≤60 years old.
Prevalence (%) of allergic sensitization by sex, area and age group
| | | | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Cat | 5.2 | 3.9 | 0.454 | 5.6 | 4.0 | 0.391 | 5.4 | 3.5 | 0.299 |
| Dog | 3.6 | 3.9 | 0.875 | 6.1 | 2.5 | 0.039 | 4.7 | 2.7 | 0.241 |
| Any animal | 8.0 | 5.6 | 0.271 | 9.5 | 5.4 | 0.073 | 7.9 | 5.5 | 0.265 |
| Cockroach | 16.5 | 10.2 | 0.033 | 11.7 | 13.8 | 0.496 | 15.1 | 11.0 | 0.159 |
| 16.5 | 10.6 | 0.045 | 19.0 | 10.5 | 0.006 | 16.9 | 9.4 | 0.011 | |
| 15.3 | 6.3 | 0.001 | 11.2 | 10.2 | 0.721 | 11.2 | 9.8 | 0.612 | |
| 27.7 | 18.7 | 0.013 | 22.9 | 22.9 | 0.995 | 27.3 | 18.0 | 0.011 | |
| Any mite | 30.9 | 21.8 | 0.017 | 27.4 | 25.4 | 0.628 | 30.6 | 21.2 | 0.014 |
| 0.8 | 0.7 | 0.895 | 0.6 | 0.8 | 0.715 | 0.7 | 0.8 | 0.931 | |
| 0.4 | 1.4 | 0.229 | 1.7 | 0.6 | 0.209 | 1.1 | 0.8 | 0.724 | |
| Any mould | 1.2 | 1.8 | 0.599 | 2.2 | 1.1 | 0.322 | 1.8 | 1.2 | 0.555 |
| Grass pollen | 2.8 | 1.4 | 0.256 | 1.7 | 2.3 | 0.654 | 2.5 | 1.6 | 0.441 |
| Tree pollen | 0.4 | 1.8 | 0.138 | 2.2 | 0.6 | 0.084 | 0.7 | 1.6 | 0.353 |
| Any pollen | 3.2 | 2.5 | 0.602 | 3.4 | 2.5 | 0.594 | 2.9 | 2.7 | 0.926 |
| Any allergen | 36.9 | 31.0 | 0.146 | 34.1 | 33.6 | 0.915 | 38.1 | 29.0 | 0.026 |
Figure 2Proportions (%) of having one, two, three or at least four positive SPT reactions among all sensitized subjects in Hoankiem and Bavi. Difference (p-value) by study area.
Figure 3Proportional Venn diagram. a) A proportional Venn diagram has been used to quantify the distribution of subjects with a positive SPT to cockroach, any mite, and any animal in the whole population sample. b) A proportional Venn diagram has been used to quantify the distribution of subjects with a positive SPT to B. tropicalis, D. pteronyssinus and D. farinae in the whole population sample.
Prevalence (%) of symptoms and diseases based on the interview among all subjects and among subjects sensitized (Yes) and not sensitized (No) to common air born allergens
| Ever asthma | 6.7 | 13.9 | 6.0 | 0.067 | 9.4 | 5.6 | 0.125 | 5.7 | 6.7 | 0.801 | 8.9 | 5.4 | 0.124 |
| Physician diagnosed asthma | 5.0 | 5.6 | 5.0 | 0.892 | 4.3 | 5.3 | 0.635 | 2.9 | 5.4 | 0.396 | 4.4 | 5.4 | 0.636 |
| Asthma medicine | 2.5 | 2.8 | 2.2 | 0.827 | 2.2 | 2.3 | 0.928 | 1.4 | 2.4 | 0.615 | 1.7 | 2.6 | 0.513 |
| Asthma attack | 2.0 | 5.6 | 1.4 | 0.063 | 2.9 | 1.3 | 0.207 | 2.9 | 1.5 | 0.419 | 3.3 | 0.9 | 0.036 |
| Asthma hospitalization | 2.5 | 2.8 | 2.0 | 0.756 | 2.9 | 1.8 | 0.435 | 0 | 2.4 | 0.213 | 2.2 | 2.0 | 0.858 |
| Wheezing last 12 months | 24.0 | 27.8 | 23.2 | 0.530 | 23.7 | 23.4 | 0.937 | 27.1 | 22.9 | 0.446 | 27.8 | 21.3 | 0.096 |
| Recurrent wheeze | 7.3 | 8.3 | 6.3 | 0.622 | 10.1 | 5.1 | 0.039 | 11.4 | 5.6 | 0.065 | 10.0 | 4.5 | 0.015 |
| Allergic rhinitis | 22.4 | 44.4 | 21.4 | 0.001 | 30.9 | 20.1 | 0.009 | 38.6 | 20.6 | 0.001 | 32.8 | 17.9 | <0.001 |
| AR symptoms last 12 months | 19.5 | 44.4 | 17.8 | <0.001 | 28.1 | 16.6 | 0.003 | 33.3 | 17.5 | 0.002 | 29.6 | 14.5 | <0.001 |
| Intermittent AR | 16.2 | 25.0 | 15.7 | 0.145 | 23.0 | 14.0 | 0.013 | 21.4 | 15.6 | 0.215 | 22.8 | 13.0 | 0.004 |
| Persistent AR | 5.1 | 19.4 | 4.5 | <0.001 | 7.2 | 4.9 | 0.290 | 14.5 | 4.1 | <0.001 | 8.4 | 4.0 | 0.034 |
*Difference (p-value) in prevalence of symptoms and diseases among sensitized v.s non-sensitized subjects.
Prevalence (%) of symptoms and diseases by number of positive SPT reactions
| Ever asthma | 5.4 | 12.5 | 6.0 | 6.9 | 0.176 |
| Physician-diagnosed asthma | 5.4 | 6.9 | 2.0 | 3.4 | 0.594 |
| Asthma medicine | 2.6 | 0 | 4.0 | 1.7 | 0.463 |
| Asthma attack | 0.9 | 2.8 | 4.0 | 3.4 | 0.197 |
| Asthma hospitalization | 2.0 | 2.8 | 2.0 | 1.7 | 0.973 |
| Wheezing last 12 months | 21.3 | 31.9 | 24.0 | 25.9 | 0.263 |
| Recurrent wheeze | 4.5 | 9.7 | 10.0 | 10.3 | 0.114 |
| Allergic rhinitis | 17.9 | 29.2 | 28.0 | 41.4 | <0.001 |
| AR symptoms last 12 months | 14.5 | 25.4 | 28.0 | 36.2 | <0.001 |
| Intermittent AR | 13.0 | 18.1 | 22.0 | 29.3 | 0.010 |
| Persistent AR | 4.0 | 7.1 | 6.0 | 12.1 | 0.080 |
| Bronchial hyper-reactivity, PC20 ≤ 2 mg/ml | 7.1 | 10.2 | 11.4 | 17.1 | 0.047 |
*Difference (p-value) in prevalence of symptoms and diseases by number of positive SPT reactions.